BR9406227A - Pharmaceutical compositions comprising paracetamol and L-cysteine or a precursor thereof - Google Patents

Pharmaceutical compositions comprising paracetamol and L-cysteine or a precursor thereof

Info

Publication number
BR9406227A
BR9406227A BR9406227A BR9406227A BR9406227A BR 9406227 A BR9406227 A BR 9406227A BR 9406227 A BR9406227 A BR 9406227A BR 9406227 A BR9406227 A BR 9406227A BR 9406227 A BR9406227 A BR 9406227A
Authority
BR
Brazil
Prior art keywords
cysteine
precursor
paracetamol
pharmaceutical compositions
hydroxyacetanilide
Prior art date
Application number
BR9406227A
Other languages
Portuguese (pt)
Inventor
Roger Spencer Jones
Original Assignee
British Tech Group
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by British Tech Group filed Critical British Tech Group
Publication of BR9406227A publication Critical patent/BR9406227A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

An improved process for the production of a pharmaceutical composition comprising p-hydroxyacetanilide and L-cysteine or a compound which is converted thereto in vivo comprises mixing p-hydroxyacetanilide and L-cysteine or its precursor in the solid state and then shaping the solid mixture.
BR9406227A 1993-03-12 1994-03-08 Pharmaceutical compositions comprising paracetamol and L-cysteine or a precursor thereof BR9406227A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB939305058A GB9305058D0 (en) 1993-03-12 1993-03-12 Pharmaceutical compositions
PCT/GB1994/000446 WO1994020086A1 (en) 1993-03-12 1994-03-08 Pharmaceutical compositions comprising paracetamol and l-cysteine or a precursor thereof

Publications (1)

Publication Number Publication Date
BR9406227A true BR9406227A (en) 1995-12-12

Family

ID=10731916

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9406227A BR9406227A (en) 1993-03-12 1994-03-08 Pharmaceutical compositions comprising paracetamol and L-cysteine or a precursor thereof

Country Status (20)

Country Link
US (2) US5716991A (en)
EP (2) EP0689434B1 (en)
JP (1) JPH08507305A (en)
KR (1) KR960700701A (en)
CN (1) CN1118989A (en)
AT (2) ATE314842T1 (en)
AU (1) AU674934B2 (en)
BR (1) BR9406227A (en)
CA (1) CA2157921C (en)
DE (2) DE69431151T2 (en)
DK (1) DK0689434T3 (en)
ES (2) ES2254541T3 (en)
GB (2) GB9305058D0 (en)
IL (1) IL108937A (en)
NO (1) NO318493B1 (en)
NZ (1) NZ262168A (en)
PT (1) PT689434E (en)
SG (1) SG48344A1 (en)
WO (1) WO1994020086A1 (en)
ZA (1) ZA941674B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5882298A (en) * 1997-01-29 1998-08-18 Chong Kun Dang Corporation New analgesic composition
AU4085201A (en) * 2000-03-15 2001-09-24 Imperial College Innovations Limited Pharmaceutical composition
KR100379155B1 (en) * 2000-07-18 2003-04-08 삼진제약주식회사 New analgesic composition
US6623754B2 (en) 2001-05-21 2003-09-23 Noveon Ip Holdings Corp. Dosage form of N-acetyl cysteine
US20080188439A1 (en) * 2006-10-26 2008-08-07 Salhanick Steven D Directed metabolism of compounds by glucuronidation and sulfonation donors to decrease toxicity
ITMI20080187A1 (en) * 2008-02-07 2009-08-08 Velleja Res Srl AMINO ACID FORMULATIONS FOR THE PREVENTION OF HEPATIC PARACETAMOL DAMAGE
CN105687177A (en) * 2009-07-15 2016-06-22 小利兰·斯坦福大学托管委员会 N-acetyl cysteine compositions and methods to improve the therapeutic efficacy of acetaminophen
ITMI20130874A1 (en) * 2013-05-29 2014-11-30 Zambon Spa DEGLUTIBLE TABLETS OF N-ACETYLCISTEIN

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3200039A (en) * 1962-05-28 1965-08-10 Pfizer & Co C Non-granulated tablets with 20% sorbitol in a particle size of from about 100mu to about 2000mu
GB1287431A (en) * 1969-04-16 1972-08-31 Aspro Nicholas Ltd Improvements in pharmaceutical formulations
GB1390032A (en) * 1971-08-27 1975-04-09 Sterling Winthrop Group Ltd Pharmaceutical compositions
GB1410909A (en) * 1971-10-26 1975-10-22 Sterling Winthrop Group Ltd Pharmaceutical compositions
GB1463505A (en) * 1973-11-21 1977-02-02 Nat Res Dev Pharmaceutical compositions
GB1583602A (en) * 1977-05-26 1981-01-28 Sterwin Ag N-acetyl-para-aminophenyl-n'-acetyl-amino-thioalkanoic acid ester derivatives
DE3173600D1 (en) * 1980-05-20 1986-03-13 Mallinckrodt Inc Spray dried n-acetyl-p-aminophenol compositions and method for manufacture thereof
US4439453A (en) * 1980-12-22 1984-03-27 Monsanto Company Directly compressible acetaminophen granulation
GR79340B (en) * 1982-07-06 1984-10-22 Sterwin Ag
US4600579A (en) * 1983-06-07 1986-07-15 Mallinckrodt, Inc. N-acetyl-p-aminophenol compositions containing partially gelatinized starch and method for preparing same
US4760093A (en) * 1986-10-21 1988-07-26 American Home Products Corporation (Del.) Spray dried acetaminophen
US5037658A (en) * 1989-09-14 1991-08-06 Hoechst-Roussel Pharmaceuticals, Inc. Direct dry compressible acetaminophen composition
EP0481294B2 (en) * 1990-10-19 2001-04-11 Spirig Ag Pharmazeutische Präparate Solid fast-dissolving pharmaceutical preparation containing N-acetyl-cysteine
US5474757A (en) * 1992-10-16 1995-12-12 Rutgers University Prevention of acetaminophen overdose toxicity with organosulfur compounds
FR2708602B1 (en) * 1993-08-02 1995-10-06 Oreal Process for the extraction of smelly compounds present in a formulation containing at least one compound comprising a thiol group and deodorized compositions thus obtained.
US5370878A (en) * 1993-09-30 1994-12-06 Hallmark Pharmaceuticals, Inc. Method for preparing a direct compression granulated acetaminophen composition
JPH07130367A (en) * 1993-10-29 1995-05-19 Sony Corp Manufacture of positive active material for lithium secondary battery

Also Published As

Publication number Publication date
SG48344A1 (en) 1998-04-17
IL108937A0 (en) 1994-06-24
GB9305058D0 (en) 1993-04-28
CN1118989A (en) 1996-03-20
AU674934B2 (en) 1997-01-16
DE69434600D1 (en) 2006-03-30
EP0689434A1 (en) 1996-01-03
GB2276319A (en) 1994-09-28
ATE221777T1 (en) 2002-08-15
IL108937A (en) 1999-10-28
ES2176238T3 (en) 2002-12-01
DE69431151D1 (en) 2002-09-12
CA2157921A1 (en) 1994-09-15
WO1994020086A1 (en) 1994-09-15
ATE314842T1 (en) 2006-02-15
CA2157921C (en) 2006-07-11
NO953515L (en) 1995-09-07
US5716991A (en) 1998-02-10
NO953515D0 (en) 1995-09-07
EP1210939A2 (en) 2002-06-05
NZ262168A (en) 1997-05-26
DE69434600T2 (en) 2006-08-24
JPH08507305A (en) 1996-08-06
AU6148794A (en) 1994-09-26
DK0689434T3 (en) 2002-12-02
DE69431151T2 (en) 2002-12-12
EP1210939B1 (en) 2006-01-04
ZA941674B (en) 1995-09-11
EP1210939A3 (en) 2002-08-07
EP0689434B1 (en) 2002-08-07
KR960700701A (en) 1996-02-24
GB9404427D0 (en) 1994-04-20
NO318493B1 (en) 2005-03-29
PT689434E (en) 2002-12-31
GB2276319B (en) 1997-01-15
ES2254541T3 (en) 2006-06-16
US5852055A (en) 1998-12-22

Similar Documents

Publication Publication Date Title
ATE71375T1 (en) SUBSTITUTED 6-FLUORO-4-OXO-1,4-DIHYDROCHINOLINE-3-CARBONIC ACID ; THEIR DERIVATIVES; PHARMACEUTICAL PREPARATIONS CONTAINING THESE COMPOUNDS AND PROCESSES FOR THE PREPARATION OF THESE COMPOUNDS.
AU588837B2 (en) Polypeptide
HUT56379A (en) Process for producing a-norsteroid-3-carboxylic acid derivatives and compositions comprising such compounds
YU174490A (en) NEW THIENYL-CARBOXYLIC ACID ESTERS WITH AMINO ALCOHOLS, THEIR QUATERAL COMPOUNDS AS WELL AS THE PREPARATION AND APPLICATION OF THESE COMPOUNDS
GR3001889T3 (en) Prodrug compounds, process for the preparation thereof and sustained release preparation comprising the same
HUT50486A (en) Process for production of neuropeptid y antaginists and medical compositions containing them as active substance
UA12648A (en) METHOD OF OBTAINING SOLID PHARMACEUTICAL FORM
BR9406227A (en) Pharmaceutical compositions comprising paracetamol and L-cysteine or a precursor thereof
DE69034226D1 (en) Preparation process of huperzine A and its analogs and compounds useful thereto
HUT54657A (en) Process for producing amino acid antagonists with vitalizing effect and pharmaceutical compositions comprising such compounds
NO932517L (en) 5,10-methylenetetrahydrofolic acid cyclodextrin inclusion compound is
HUT54988A (en) Process for producing substituted n-(quinolin-2-ylmethoxy)-benzylsulfonylureas and pharmaceutical compositions comprising such compounds
DE3868013D1 (en) THIAZOLE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN IT.
BR9304780A (en) Compound, process for preparing the compound, pharmaceutical composition and use
IL86169A0 (en) Substituted quinoxalyl-imidazolidine-2,4-diones,processes for their preparation and pharmaceutical compositions containing them
HUT57746A (en) Process for producing new 1,3-oxazines and pharmaceutical compositions comprising same
PT88578A (en) PROCESS FOR THE MANUFACTURE OF 2,6-METHANOPYRROL-3-BENZAZOCINES OF INTERMEDIATES USEFUL FOR THEIR MANUFACTURE AND OF PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
AU577570B2 (en) Mefloquine quinates
ATE28189T1 (en) 2-ALKYLTHIO-1-AMINOALKYL-2-PYRROLINE-3CARBONITRILES, PROCESS FOR THEIR PRODUCTION AND MEDICINES CONTAINING THEM FOR THE PROPHYLAXIS AND THERAPY OF THROMBOTIC CONDITIONS.
EP0104596A3 (en) Furoindole derivatives
ES8305712A1 (en) Process for the preparation of a lower alkyl 1,4-di lower alkyl-3-lower alkoxycarbonyl-pyrrole-2-acetate

Legal Events

Date Code Title Description
EG Technical examination (opinion): publication of technical examination (opinion)
FC Decision: refusal
TC Change of name
TE Change of address
CKFC Appeal: appeal against refusal